Predictive modeling of mortality in carbapenem-resistant bloodstream infections using machine learning.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
PMID:

Abstract

, a notable drug-resistant bacterium, often induces severe infections in healthcare settings, prompting a deeper exploration of treatment alternatives due to escalating carbapenem resistance. This study meticulously examined clinical, microbiological, and molecular aspects related to in-hospital mortality in patients with carbapenem-resistant . (CRAB) bloodstream infections (BSIs). From 292 isolates, 153 cases were scrutinized, reidentified through matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), and evaluated for antimicrobial susceptibility and carbapenemase genes via multiplex polymerase chain reaction (PCR). Utilizing supervised machine learning, the study constructed models to predict 14- and 30-day mortality rates, revealing the Naïve Bayes model's superior specificity (0.75) and area under the curve (0.822) for 14-day mortality, and the Random Forest model's impressive recall (0.85) for 30-day mortality. These models delineated eight and nine significant features for 14- and 30-day mortality predictions, respectively, with "septic shock" as a pivotal variable. Additional variables such as neutropenia with neutropenic days prior to sepsis, mechanical ventilator support, chronic kidney disease, and heart failure were also identified as ranking features. However, empirical antibiotic therapy appropriateness and specific microbiological data had minimal predictive efficacy. This research offers foundational data for assessing mortality risks associated with CRAB BSI and underscores the importance of stringent infection control practices in the wake of the scarcity of new effective antibiotics against resistant strains. The advanced models and insights generated in this study serve as significant resources for managing the repercussions of . infections, contributing substantially to the clinical understanding and management of such infections in healthcare environments.

Authors

  • Murat Özdede
    Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, TUR.
  • Pınar Zarakolu
    Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Gökhan Metan
    Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Özgen Köseoğlu Eser
    Department of Medical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Cemile Selimova
    Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Canan Kızılkaya
    bioMerieux SA, İstanbul, Turkey.
  • Ferhan Elmalı
    Department of Biostatistics, Katip Çelebi University, Faculty of Medicine, İzmir, Turkey.
  • Murat Akova
    Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.